Equities
Molson Coors Brewing Co stock reaches 52-week low at $38.03
Stock trades nearly 31% below its 52-week high of $54.82, reflecting broader challenges in the brewing industry and softer consumer trends.
Lesaka Technologies Posts Q4 FY26 Profitability Turnaround, Sets Aggressive Growth Ambitions
Net revenue rose 8% year-over-year, adjusted EBITDA hit a record high, and full-year GAAP net income turned positive amid strategic expansions.
Nuveen Municipal Credit Income hits 52‑week low of $11.54
The fund’s shares fell to $11.54, below the prior low of $11.65, as the RSI indicated oversold conditions.
Melco Resorts Misses Q2 2026 Earnings as Stock Drops to 52-Week Low
Macau’s Melco Resorts & Entertainment reports weaker-than-expected results amid lower visitation and VIP gaming performance, pushing stock to a fresh low.
US equities slide as Fed, oil prices and inflation concerns weigh on markets
Dow Jones, Nasdaq 100 and S&P 500 all decline amid geopolitical tensions, rising oil prices and investor fears of Fed rate hikes
Ionis Pharmaceuticals Reports Setbacks in Key Programs Amid U.S. Healthcare Conference
Ionis Pharmaceuticals (IONS) highlighted two failed clinical trials and revenue pressures during its presentation at Wells Fargo’s 21st Annual Healthcare Conference, while emphasizing recent FDA approvals and pipeline momentum.
Shentel’s Fiber Expansion Drives 2026 Revenue Growth Amid Debt Refinancing
Shentel’s fiber business, Glo Fiber, surpassed legacy revenue in Q2 2024 and is set to deploy over 510,000 fiber connections by year-end 2026, with guidance for 4% revenue and 12% EBITDA growth in 2026.
Enablence Raises C$25M in Private Placement
Enablence Technologies Inc. completes private placement, issuing 3.23 million shares at C$7.75 each to Collingwood Investments Incorporated, with Paradigm Capital Inc. as financial advisor.
Kinetik Holdings Stock Reaches 52-Week High at $56.76
The AI-driven hardware company reported strong second-quarter earnings and raised full-year EBITDA guidance, despite a rating downgrade by Clear Street.
Energy Transfer Hits 52-Week High as Q2 Earnings and Dividend Hold Steady
Energy Transfer stock surged to $21.78 on Q2 adjusted EPS of $0.59, well above the $0.37 forecast, supported by a 30.8% jump in adjusted EBITDA to $5.1 billion and a maintained 6.3% dividend yield.
Permian Basin Royalty Trust hits $35.52 high as YTD return hits 109.5%
The Permian Basin Royalty Trust’s stock reached an all-time high of $35.52 on September 10, 2026, with a year-to-date return of 109.5% and a one-year gain of 96.3%.
Dutch Bros Stock Hits 52-Week Low as After-Hours Sell-Off Follows Q2 Beat
Coffee chain’s shares slipped below $44.50 despite a second-quarter earnings beat, weighed down by softer guidance and cost pressures.
SL Science Holding shares hit 52-week low of $2.45
The stock fell 17% this week to $2.45, 83% below its 52‑week high, as the company seeks FDA orphan‑drug status for a glioblastoma therapy.
SMI sinkt vorbörslich leicht, Halbleiteraktien dominieren Verluste
Schweizer Aktienmärkte zeigen vor dem Wochenauftakt leichte Schwäche, getrieben durch Verluste bei 19 von 20 SMI-Titeln, während US-Zinsentscheidungen und Ölpreise weitere Risiken für globale Indizes schaffen.
Neurocrine Biosciences Expands Growth with Three Products, Reaffirms 2025 Guidance
The biotech firm projects $2.85 billion in revenue for 2025, driven by INGREZZA’s long-term exclusivity and pipeline expansion in psychiatry and neurology.
ETFs dominate global assets: $1.07T VOO leads $3T+ S&P 500 ETF market
Exchange-traded funds (ETFs) have surged past active funds, with the Vanguard S&P 500 ETF (VOO) leading $3 trillion in global index-tracking assets as of mid-September 2026.
AI-linked stocks fall as slowdown call worries investors
Shares in AI-linked companies in Asia drop as leading figures call for a slowdown in development, raising concerns about infrastructure costs and credit risk.
Verastem Discusses Dual-Track Growth Strategy at Cantor Conference
Verastem presents its dual-track growth strategy at the Cantor Fitzgerald Global Healthcare Conference, highlighting its commercial product and potential blockbuster G12D inhibitor.
Currency Exchange International Posts Q3 2026 Revenue Growth Amid Payments Surge
Currency Exchange International Corp. reported a 5% year-over-year rise in Q3 2026 revenue to $22.4 million, driven by a 54% jump in payments revenue, while banknotes revenue declined slightly.
Lesaka Posts Q4 2026 EPS Beat, Shares Rise on Growth Guidance
Lesaka Technologies Inc. reported stronger-than-expected Q4 2026 earnings, with adjusted EPS exceeding forecasts and revenue growth across divisions, though merchant division results lagged.
Haivision Q3 2026 revenue drops 1.4% as tariffs weigh on margins
Revenue fell to CAD 34.5 million amid analyst misses and tariffs on key products, while adjusted EBITDA margins declined sharply.
Gemini stock down 80% since IPO, sparking takeover speculation
Gemini's market value fell to about $753 million from a $4 billion peak as revenue, volume and assets contracted, prompting talk of a sale to acquire its U.S. crypto licences.
Napo Pharmaceuticals advances MVID trial toward 2027 filing
Jaguar Health's Napo unit presents data at ESPGHAN meeting, targeting mid-2027 NDA filing for microvillus inclusion disease treatment.
Avalanche Treasury Adds Virginia Gambale to Board with Blockchain, AI Expertise
Virginia Gambale joins Avalanche Treasury Co. as a board director, bringing over 20 years of experience in technology leadership and public markets advisory.